39 studies found for: " November 17, 2010":" December 17, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.
Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.
Will Having Alcohol Treatment Improve Functioning?
A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir
Vitamin D in HIV-Infected Patients on HAART
Study of SystemCHANGE-HIV
Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Populations Using Formula Feeding (PROMISE)
Addition of Raltegravir to Established Antiretroviral Suppressive Therapy
|29||Active, not recruiting||
Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults
The Effect of Pregnancy on the PK of Isentress®: A Longitudinal Investigation in the Second and Third Trimesters
|31||Active, not recruiting||
HIV Prevention for PLHIV: Evaluation of an Intervention Toolkit for HIV Care & Treatment Settings
Cameroon Mobile Phone SMS Trial
|33||Active, not recruiting||
Preparing for International Prevention Trials Involving HIV-Infected Individuals in Care Settings
A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022
Familias Unidas: Preventing Drug Abuse and HIV in Hispanic First Offenders
Ondansetron, Alcohol Use, and Alcohol-Related Symptoms In HIV+ Persons
Understanding Medication Adherence Among HIV Patients
Effects of an Evidence Service on Community-based AIDS Service Organizations' Use of Research Evidence
Adherence, Improvement Measure (AIM) System
† Indicates status has not been verified in more than two years